Summit Tx Capital, L.P. Agios Pharmaceuticals, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 10,768 shares of AGIO stock, worth $304,303. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,768Holding current value
$304,303% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.2MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$161 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$158 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$137 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$99.3 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$69.2 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.55B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...